Table 1.
Frequencies in percentage (%), mean age (M) and standard deviation (SD) of the characteristics of the sample of participants.
| % | M | SD | |
|---|---|---|---|
| F | 54.2 | 55.88 | 71.14 |
| M | 45.8 | 56.89 | 27.67 |
| 1 dose | 65.8 | 54.21 | 26.26 |
| 2 dose | 34.2 | 60.16 | 86.97 |
| Cominarty (Pfizer-BioNTech) | 75.7 | 60.51 | 62.36 |
| Vaxzevria (Astrazeneca) | 24.3 | 42.48 | 11.91 |
| Medical and health personnel | 28.1 | 38.39 | 27.19 |
| Administrative staff | 10.6 | 46.22 | 11.32 |
| School staff | 15.6 | 43.41 | 11.7 |
| University staff | 3.1 | 29.96 | 3.8 |
| People with frailty | 10.3 | 47.45 | 14.03 |
| People with disabilities | 0.4 | 52.43 | 7.8 |
| Law enforcement agencies | 1.1 | 46.82 | 10.24 |
| People with advanced age | 28.8 | 87.73 | 88.32 |
| Subjects aged between 70–79 years | 2 | 74.93 | 4.61 |